Skip to content
Drug recall · FDA · Published October 23, 2023

Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals

Glenmark Pharmaceuticals recalls 500mg Ranolazine Extended-Release Tablets due to failed dissolution specifications. Rx-only medication with specific lot number and expiration date.

🇺🇸 FDA recall #D-0092-2024DrugGlenmark ›
Take action

Contact the company & request your remedy

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Glenmark Pharmaceuticals is recalling 500mg Ranolazine Extended-Release Tablets because they failed dissolution tests. This means the medication may not work as intended when taken. The recall applies to specific lot numbers and expiration dates. Read more at govinfonow.com/recall/33034-glenmark-ranolazine-extended-release-tablets-500mg-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/33034-glenmark-ranolazine-extended-release-tablets-500mg-failed-dissolution-specifications · Updated September 23, 2026 · FDA enforcement record: FDA #D-0092-2024

Cite this page

“Glenmark Ranolazine Extended-Release Tablets 500mg: Failed Dissolution Specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33034-glenmark-ranolazine-extended-release-tablets-500mg-failed-dissolution-specifications. Based on FDA recall #D-0092-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0092-2024%22&limit=1).

Why it’s dangerous

The medication failed dissolution specifications, meaning it may not release the active ingredient properly in the body. This could lead to inconsistent drug levels, but it does not cause immediate harm or injury.

Who’s affected

Prescription drug users who purchased the specific lot number (17230388) of Ranolazine Extended-Release Tablets 500mg from the manufacturer. Patients on this medication are most at risk.

How to tell if you have this one

Check for the lot number 17230388 on the bottle label. The product expires January 31, 2025. This recall applies to Rx-only medication sold by Glenmark Pharmaceuticals.

  • Brand
    Glenmark
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number 17230388 on the bottle label and expiration date of January 31, 2025.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall is due to failed dissolution specifications, which may affect how the medication works but does not cause immediate harm. Consult your doctor for advice.

What should I do if I have this medication?

Check the lot number and expiration date. If it matches the recalled batch, contact your doctor or pharmacist for guidance.

How can I confirm if my medication is recalled?

Look for the lot number 17230388 on the bottle label and expiration date of January 31, 2025.

Take action

Contact Glenmark

We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.

Subject: Recall D-0092-2024 — Glenmark Glenmark

Hello,

I own a Glenmark that is covered by recall D-0092-2024 from Glenmark.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0092-2024 (October 23, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0092-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA